Cite
Vos MB, Jin R, Konomi JV, et al. A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease. Pilot Feasibility Stud. 2018;4:109doi: 10.1186/s40814-018-0306-4.
Vos, M. B., Jin, R., Konomi, J. V., Cleeton, R., Cruz, J., Karpen, S., Rodriguez, D. S., Frediani, J. K., McCracken, C., & Welsh, J. (2018). A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease. Pilot and feasibility studies, 4109. https://doi.org/10.1186/s40814-018-0306-4
Vos, Miriam B, et al. "A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease." Pilot and feasibility studies vol. 4 (2018): 109. doi: https://doi.org/10.1186/s40814-018-0306-4
Vos MB, Jin R, Konomi JV, Cleeton R, Cruz J, Karpen S, Rodriguez DS, Frediani JK, McCracken C, Welsh J. A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease. Pilot Feasibility Stud. 2018 Jun 05;4:109. doi: 10.1186/s40814-018-0306-4. eCollection 2018. PMID: 29992039; PMCID: PMC5987658.
Copy
Download .nbib